title: Detection of leukemia associated antigen-specific cytotoxic T cells in a patient with Philadelphia chromosome-positive leukemia during treatment with dasatinib.
authors.affiliation: Division of Clinical Physiology and Therapeutics, Keio University Faculty of Pharmacy , Tokyo , Japan.
authors.forename: Maiko
authors.initials: M
authors.lastname: Matsushita
authors.forename: Koharu
authors.initials: K
authors.lastname: Tonegawa
authors.forename: Takehiko
authors.initials: T
authors.lastname: Mori
authors.forename: Sumiko
authors.initials: S
authors.lastname: Kohashi
authors.forename: Jun
authors.initials: J
authors.lastname: Kato
authors.forename: Eri
authors.initials: E
authors.lastname: Matsuki
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Okamoto
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Hattori
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000069439:Dasatinib; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D013844:Thiazoles / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D018984:Epitopes, T-Lymphocyte; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib